Filing Details
- Accession Number:
- 0001415889-23-000801
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-11 16:25:04
- Reporting Period:
- 2023-01-10
- Accepted Time:
- 2023-01-11 16:25:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1733294 | Generation Bio Co. | GBIO | Pharmaceutical Preparations (2834) | 814301281 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1907682 | Antoinette Paone | C/O Generation Bio Co., 301 Binney St Cambridge MA 02142 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-01-10 | 1,865 | $4.57 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2022.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $4.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Includes 1,865 shares acquired under the company's employee stock purchase plan since October 28, 2022.
Billionaire Hedge Funds
